TLRY Tilray Brands, Inc.
$2.75▲ +1.22%
Healthcare
Other
Volume 963.3K
Avg Volume (10D) 3.79M
Key Metrics & Fundamentals
Market Cap
$406.87M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.68 - 15.70
% vs 50 MA
-31.07%
% vs 200 MA
-51.49%
RSI-14
19.4
MACD Histogram
-0.0400
Beta (1Y vs SPY)
1.51
Free Cash Flow
-$27.55M
Gross Rev
$257.15M
Gross Profit
$77.51M
EBITDA
$5.96M
COGS
$179.64M
Operating Exp
$93.63M
Operating Income
-$16.12M
EBIT
-$16.12M
Pretax Income
-$38.31M
Net Income
-$43.14M
EPS (Diluted)
-0.32
Price & Volume History
Loading chart…
Recent News
Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out?
Motley Fool · Oct 27, 2026 9:06 AM ET
Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors.
Motley Fool · Oct 25, 2026 7:35 AM ET
Blue Point Brewing Co.’s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews
GlobeNewswire · Oct 22, 2026 7:00 AM ET
West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers
GlobeNewswire · Oct 21, 2026 7:00 AM ET
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive · Oct 19, 2026 9:22 AM ET
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
Motley Fool · Oct 15, 2026 6:14 PM ET
SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
GlobeNewswire · Oct 15, 2026 7:00 AM ET
Tilray Medical's Portugal Lab Granted Approval for In-House Testing
MT Newswires · Oct 13, 2026 7:24 AM ET
Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
GlobeNewswire · Oct 13, 2026 7:00 AM ET
3 Huge Red Flags From Tilray's Q1 Earnings Report
Motley Fool · Oct 12, 2026 2:45 PM ET
Financial Overview - Income Statement
Quarterly
Aug 2026
See TLRY's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.